Article
Benchmarking fragmentation-derived artificial cfDNA reference standards
2026-08-17
Abstract excerpt
An important step toward clinical implementation of (epi-)genomic assays on liquid biopsies is their validation on identical samples within and across laboratories. For these validation studies, there is a need for cell-free DNA (cfDNA) samples with defined tumor fractions and (epi-)genomic aberrations. However, the amount of circulating cfDNA isolated from patient samples is often limited, especially in pediatric...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5eb34450-6060-5fed-ae1e-18f4ec627370
- DOI
- 10.64898/2026.08.12.744389
